1 Min Read
Sept 8 (Reuters) - Bristol-Myers Squibb Co
* Bristol-Myers Squibb Co completes previously announced acquisition of IFM Therapeutics
Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.